Epoch Investment Partners, Inc. Corcept Therapeutics Inc Transaction History

Epoch Investment Partners, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $891,842 - $1.05 Million	36,107 Added 3.34%	1,115,854 $28.6 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $167,910 - $245,131	9,689 Added 0.91%	1,079,747 $25.7 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $1.99 Million - $3.03 Million	-120,312 Reduced 10.11%	1,070,058 $24.1 Million
Q4 2021 Feb 11, 2022	BUY	$17.1 - $23.34 $4.46 Million - $6.09 Million	260,964 Added 28.08%	1,190,370 $23.6 Million
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $3.96 Million - $4.53 Million	200,987 Added 27.59%	929,406 $18.3 Million
Q2 2021 Aug 13, 2021	BUY	$19.97 - $24.43 $11.2 Million - $13.6 Million	558,623 Added 329.0%	728,419 $16 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $3.99 Million - $5.19 Million	169,796 New	169,796 $4.04 Million

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Epoch Investment Partners, Inc. with notifications on news.